Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Allergy ; 71(5): 640-50, 2016 05.
Article in English | MEDLINE | ID: mdl-26752231

ABSTRACT

BACKGROUND: Glucocorticoid resistance has been associated with Th17-driven inflammation, the mechanisms of which are not clear. We determined whether human and mouse Th17 cells are resistant to glucocorticoid-induced apoptosis. METHODS: Freshly isolated human blood Th17 cells and in vitro differentiated Th17 cells from IL-17F red fluorescent protein reporter mice were treated with dexamethasone, a potent glucocorticoid. Apoptosis was measured using annexin V and DAPI staining. Screening of apoptosis genes was performed using the apoptosis PCR array. Levels of molecules involved in apoptosis were measured using quantitative RT-PCR, flow cytometry, and Western blotting. Knockdown of BCL-2 in murine Th17 cells was performed via retroviral transduction. Cytokines were measured using ELISA. A murine Th17-driven severe asthma model was examined for Th17 glucocorticoid sensitivity in vivo. RESULTS: Human and mouse Th17 cells and mouse Th2 cells were resistant to glucocorticoid-induced apoptosis. Th17 cells had glucocorticoid receptors levels comparable to those in other T effectors cells. Th17 cells had high levels of BCL-2, knockdown of which sensitized Th17 cells to dexamethasone-induced apoptosis. Production of IL-22, but not IL-17A and IL-17F, was suppressed by glucocorticoids. STAT3 phosphorylation in Th17 cells was insensitive to glucocorticoid inhibition. Lung Th17 cells in the murine severe asthma model were enhanced, rather than suppressed, by glucocorticoids. CONCLUSION: Th17 cells are resistant to glucocorticoid-induced apoptosis and cytokine suppression, at least in part due to high levels of BCL-2. These findings support a role of Th17 cells in glucocorticoid-resistant inflammatory conditions such as certain endotypes of asthma.


Subject(s)
Apoptosis/drug effects , Apoptosis/genetics , Genes, bcl-2 , Glucocorticoids/pharmacology , Th17 Cells/drug effects , Th17 Cells/metabolism , Animals , Asthma/genetics , Asthma/immunology , Asthma/metabolism , Asthma/pathology , Biomarkers , Cytokines/genetics , Cytokines/metabolism , Disease Models, Animal , Drug Resistance/genetics , Gene Expression , Gene Knockdown Techniques , Humans , Immunophenotyping , Lung/immunology , Lung/metabolism , Lung/pathology , Mice , T-Lymphocyte Subsets/drug effects , T-Lymphocyte Subsets/immunology , T-Lymphocyte Subsets/metabolism , Th17 Cells/immunology , Th2 Cells/drug effects , Th2 Cells/immunology , Th2 Cells/metabolism
2.
Free Radic Biol Med ; 47(6): 750-9, 2009 Sep 15.
Article in English | MEDLINE | ID: mdl-19524665

ABSTRACT

8-Oxoguanine DNA glycosylase (Ogg1) repairs 8-oxo-7,8-dihydroxyguanine (8-oxoG), one of the most abundant DNA adducts caused by oxidative stress. In the mitochondria, Ogg1 is thought to prevent activation of the intrinsic apoptotic pathway in response to oxidative stress by augmenting DNA repair. However, the predominance of the beta-Ogg1 isoform, which lacks 8-oxoG DNA glycosylase activity, suggests that mitochondrial Ogg1 functions in a role independent of DNA repair. We report here that overexpression of mitochondria-targeted human alpha-hOgg1 (mt-hOgg1) in human lung adenocarcinoma cells with some alveolar epithelial cell characteristics (A549 cells) prevents oxidant-induced mitochondrial dysfunction and apoptosis by preserving mitochondrial aconitase. Importantly, mitochondrial alpha-hOgg1 mutants lacking 8-oxoG DNA repair activity were as effective as wild-type mt-hOgg1 in preventing oxidant-induced caspase-9 activation, reductions in mitochondrial aconitase, and apoptosis, suggesting that the protective effects of mt-hOgg1 occur independent of DNA repair. Notably, wild-type and mutant mt-hOgg1 coprecipitate with mitochondrial aconitase. Furthermore, overexpression of mitochondrial aconitase abolishes oxidant-induced apoptosis whereas hOgg1 silencing using shRNA reduces mitochondrial aconitase and augments apoptosis. These findings suggest a novel mechanism that mt-hOgg1 acts as a mitochondrial aconitase chaperone protein to prevent oxidant-mediated mitochondrial dysfunction and apoptosis that might be important in the molecular events underlying oxidant-induced toxicity.


Subject(s)
Adenocarcinoma/enzymology , DNA Glycosylases/metabolism , Lung Neoplasms/enzymology , Mitochondria/enzymology , Mutant Proteins/metabolism , Aconitate Hydratase/metabolism , Adenocarcinoma/genetics , Adenocarcinoma/pathology , Apoptosis/genetics , Caspase 9/metabolism , Cell Line, Tumor , DNA Glycosylases/genetics , DNA Repair/genetics , Epithelial Cells/pathology , Humans , Lung/pathology , Lung Neoplasms/genetics , Lung Neoplasms/pathology , Mutant Proteins/genetics , Oxidative Stress , Transgenes/genetics
SELECTION OF CITATIONS
SEARCH DETAIL